Cargando…
Urinary cMet as a prognostic marker in immunoglobulin A nephropathy
The prediction of prognosis in patients with immunoglobulin A nephropathy (IgAN) is challenging. We investigated the correlation between urinary cMet (ucMet) levels and clinical parameters and examined the effects of cMet agonistic antibody (cMet Ab) in an in vitro IgAN model. Patients diagnosed wit...
Autores principales: | An, Jung Nam, Li, Lilin, Lee, Junghun, Yu, Seung‐Shin, Kim, Jin Hyuk, Lee, Jeonghwan, Kim, Yong Chul, Kim, Dong Ki, Oh, Yun Kyu, Lim, Chun Soo, Kim, Yon Su, Kim, Sunyoung, Yang, Seung Hee, Lee, Jung Pyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576300/ https://www.ncbi.nlm.nih.gov/pubmed/32822114 http://dx.doi.org/10.1111/jcmm.15636 |
Ejemplares similares
-
cMet agonistic antibody attenuates apoptosis in ischaemia‐reperfusion–induced kidney injury
por: An, Jung Nam, et al.
Publicado: (2020) -
Renoprotective effects of a novel cMet agonistic antibody on kidney fibrosis
por: Kim, Yong Chul, et al.
Publicado: (2019) -
Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy
por: Kim, Yong Chul, et al.
Publicado: (2018) -
Hepatocyte growth factor and soluble cMet levels in plasma are prognostic biomarkers of mortality in patients with severe acute kidney injury
por: Li, Lilin, et al.
Publicado: (2021) -
Progress of antibody-based inhibitors of the HGF–cMET axis in cancer therapy
por: Kim, Ki-Hyun, et al.
Publicado: (2017)